PUBLISHER: SkyQuest | PRODUCT CODE: 1463474
PUBLISHER: SkyQuest | PRODUCT CODE: 1463474
Global Medical Cannabis Market size was valued at USD 14.50 billion in 2022 and is poised to grow from USD 17.76 billion in 2023 to USD 90.07 billion by 2031, growing at a CAGR of 22.50% in the forecast period (2024-2031).
The legalization of medical marijuana in numerous countries has paved the way for its cultivation, reducing dependency on imports and bolstering tax revenue. Governments worldwide are facilitating the use of cannabis for medical purposes, as evidenced by the Delhi High Court's January 2022 decision permitting its use for medical and scientific ends in India. Extensive research has showcased medical cannabis as an effective and safer alternative for managing chronic pain compared to conventional treatments, with its affordability, natural origin, and lack of side effects being notable advantages. Ongoing studies on its efficacy in chronic pain management are poised to fuel market growth, especially considering the substantial portion of adults, as indicated in a May 2022 report, experiencing chronic pain. With increasing research endeavors and recognition of its medical merits, coupled with legal reforms and advancements in intellectual property rights, the medical cannabis market is projected to expand significantly.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Cannabis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Medical Cannabis Market Segmental Analysis
Global Medical Cannabis Market is segmented on the basis of type, application and region. By type, the market is segmented into flower, edible, concentrates, others. By application, market is segmented into cancer, pain disorders, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Medical Cannabis Market
Cannabis has been authorized to address various conditions such as chemotherapy-induced nausea and vomiting, restlessness, muscle tension, and chronic discomfort. Research on the therapeutic potential of cannabis and hemp is rapidly progressing across many industries.
Restraints in the Global Medical Cannabis Market
Consequently, the development of cannabis capsules aims to provide precise and carefully measured doses of a blend of cannabis-based medicinal compounds. The demand for these precisely calibrated cannabis capsule dosages is expected to surge globally due to their potential to effectively address various health conditions such as Alzheimer's disease, cancer, epilepsy, glaucoma, PTSD, muscular spasms, and more.
Market Trends of the Global Medical Cannabis Market
The emergence of a diverse array of cannabis-infused products such as oils, tinctures, capsules, and topical creams reflects a notable trend in the industry. This expansion not only broadens the market but also appeals to a more diverse demographic of patients, indicating a growing interest and acceptance of cannabis-based remedies.